medigraphic.com
ISSN 0210-5187 (Electronic)

2020, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2020; 48 (1)

Prevalence of mucocutaneous manifestations in patients with diabetics type 2

Morales-Godínez LC, Hernández-Pérez IR

Language: Spanish
References: 20
Page: 16-20
PDF size: 196.09 Kb.


ABSTRACT

Introduction: The skin manifestations secondary to diabetes can appear as initial symptoms of the disease or precede its primary manifestations. Such manifestations present a health problem; however, they are not diagnosed in common practice. Objective: Estimate the prevalence of mucocutaneous manifestations in type 2 diabetics. Material and methods: Cross-sectional descriptive study. 214 patients, selected in simple random form, from the diabetes and cardio-metabolic clinics of the General Hospital San Juan de Dios, were studied during 2018 and 2019. They were questioned about antecedents associated with skin manifestations and an evaluation was performed with the dermatologist. Results: The average age was: 61 years; 80.4% were women; 78.5% from the capital; 41.6% with primary schooling, 16.4% without schooling, 73.4% with high blood pressure; the average value of glycosylated hemoglobin was 7.6 and 89.7% treated with oral hypoglycemic agents. The most frequent cutaneous manifestations were infections with 53.7%; the most common was nail mycosis with 48.6%. The average of glycosylated hemoglobin was higher in patients with cutaneous manifestations (p = 0.002), with the other characteristics no association was found. Conclusions: Cutaneous manifestations are a frequent problem in patients with diabetes mellitus 2. Adequate glycemic control must be maintained, as hyperglycemia is associated with mucocutaneous manifestations.


REFERENCES

  1. Luiza A, Tanja L, Sibylle I, Peter S. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017; 18 (4): 541-553.

  2. Sam B. Situación de enfermedades no transmisibles junio 2016 [Internet]. Guatemala; 2016. Disponible en: http://epidemiologia.mspas.gob.gt/informacion/salasituacionales/vigilancia-epidemiologica

  3. De Macedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr [Internet]. 2016 [citado el 14 de octubre de 2018]; 8 (1): 63. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27583022

  4. Tseng HW, Ger LP, Liang CK, Liou HH, Lam HC. High prevalence of cutaneous manifestations in the elderly with diabetes mellitus: an institution-based cross-sectional study in Taiwan. J Eur Acad Dermatol Venereol. 2015; 29: 1631-1635.

  5. Zaballos D, Garrido A, Cía P, Lafuente E, Pinós P. Manifestaciones cutáneas de la diabetes. Med Integr. 2001; 38 (1): 36-42.

  6. Farías MM, Kolbach M, Serrano V, Hasson A. Diabetes mellitus y piel: lesiones cutáneas y su significado clínico. Rev Chil Endocrinol Diabetes. 2011; 4 (1): 26-31.

  7. González-Márquez TN, Leal-Osuna SE, Barrón-Hernández YL, Lacy-Niebla RM. Marcadores dermatológicos de enfermedades metabólicas. Derma Cosmética y Quirúrgica. 2016; 14 (1): 48-61.

  8. Barrera-Guarderas F, Santacruz-Guzmán G, Zambrano-Costales M, Serrano-Dueñas M, Gordillo-Altamirano F, Palacios-Álvarez S. Manifestaciones cutáneas en pacientes con diabetes mellitus en un centro de atención primaria en Ecuador. Dermatología Rev Mex. 2017; 61 (6): 457-473.

  9. Fajre X, Pérez L, Pardo J, Dreyse J, Herane MI. Manifestaciones cutáneas de diabetes mellitus. Rev Méd Chile. 2009; 137 (7): 894-899.

  10. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012; 26 (10): 1203-1211.

  11. Luiza A, Tanja L, Sibylle I, Peter S. Cutaneous manifestations of diabetes mellitus: a review. Am J Clin Dermatol. 2017; 18 (4): 541-553.

  12. Sam B. Situación de enfermedades no transmisibles junio 2016 [Internet]. Guatemala; 2016. Disponible en: http://epidemiologia.mspas.gob.gt/informacion/salasituacionales/vigilancia-epidemiologica

  13. De Macedo GM, Nunes S, Barreto T. Skin disorders in diabetes mellitus: an epidemiology and physiopathology review. Diabetol Metab Syndr [Internet]. 2016 [citado el 14 de octubre de 2018]; 8 (1): 63. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/27583022

  14. Tseng HW, Ger LP, Liang CK, Liou HH, Lam HC. High prevalence of cutaneous manifestations in the elderly with diabetes mellitus: an institution-based cross-sectional study in Taiwan. J Eur Acad Dermatol Venereol. 2015; 29: 1631-1635.

  15. Zaballos D, Garrido A, Cía P, Lafuente E, Pinós P. Manifestaciones cutáneas de la diabetes. Med Integr. 2001; 38 (1): 36-42.

  16. Farías MM, Kolbach M, Serrano V, Hasson A. Diabetes mellitus y piel: lesiones cutáneas y su significado clínico. Rev Chil Endocrinol Diabetes. 2011; 4 (1): 26-31.

  17. González-Márquez TN, Leal-Osuna SE, Barrón-Hernández YL, Lacy-Niebla RM. Marcadores dermatológicos de enfermedades metabólicas. Derma Cosmética y Quirúrgica. 2016; 14 (1): 48-61.

  18. Barrera-Guarderas F, Santacruz-Guzmán G, Zambrano-Costales M, Serrano-Dueñas M, Gordillo-Altamirano F, Palacios-Álvarez S. Manifestaciones cutáneas en pacientes con diabetes mellitus en un centro de atención primaria en Ecuador. Dermatología Rev Mex. 2017; 61 (6): 457-473.

  19. Fajre X, Pérez L, Pardo J, Dreyse J, Herane MI. Manifestaciones cutáneas de diabetes mellitus. Rev Méd Chile. 2009; 137 (7): 894-899.

  20. Behm B, Schreml S, Landthaler M, Babilas P. Skin signs in diabetes mellitus. J Eur Acad Dermatol Venereol. 2012; 26 (10): 1203-1211.




2020     |     www.medigraphic.com